Total Payments
$3,568
2024 Payments
$963.90
Companies
29
Transactions
206
Medicare Patients
1,867
Medicare Billing
$102,482
Payment Breakdown by Category
Food & Beverage$3,568 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,568 | 206 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,833 | 111 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $278.10 | 19 | $0 (2024) |
| Amgen Inc. | $260.20 | 10 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $186.52 | 5 | $0 (2024) |
| Organon Llc | $91.38 | 7 | $0 (2024) |
| Amarin Pharma Inc. | $89.90 | 6 | $0 (2022) |
| Biohaven Pharmaceutical Holding Company Ltd. | $76.80 | 4 | $0 (2022) |
| Biohaven Pharmaceuticals, Inc. | $69.74 | 4 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $66.36 | 3 | $0 (2023) |
| Nestle HealthCare Nutrition Inc. | $65.14 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $963.90 | 46 | ABBVIE INC. ($436.34) |
| 2023 | $1,121 | 62 | ABBVIE INC. ($584.87) |
| 2022 | $775.01 | 50 | ABBVIE INC. ($447.09) |
| 2021 | $708.65 | 48 | AbbVie Inc. ($364.89) |
All Payment Transactions
206 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: RESPIRATORY | ||||||
| 12/16/2024 | Becton, Dickinson and Company | BD Onclarity (Device) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: Diagnostic Testing | ||||||
| 11/07/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $29.62 | General |
| Category: PSYCHIATRY | ||||||
| 10/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.39 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.14 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $124.96 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.07 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $56.95 | General |
| Category: Respiratory | ||||||
| 09/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: RESPIRATORY | ||||||
| 09/12/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: Bone Health | ||||||
| 08/22/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $5.39 | General |
| Category: NEUROSCIENCE | ||||||
| 08/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/05/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: ETONOGESTREL | ||||||
| 08/02/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/16/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $26.95 | General |
| Category: Psychology/Psychiatric | ||||||
| 07/09/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: Inflammation | ||||||
| 06/25/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $81.03 | General |
| Category: Respiratory | ||||||
| 06/14/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $6.46 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: NEUROSCIENCE | ||||||
| 05/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.58 | General |
| Category: NEUROSCIENCE | ||||||
| 05/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.46 | General |
| Category: NEUROSCIENCE | ||||||
| 05/20/2024 | Edwards Lifesciences Corporation | EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: Transcatheter Heart Valves | ||||||
| 05/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 343 | 586 | $74,507 | $23,033 |
| 2022 | 11 | 506 | 745 | $88,882 | $28,220 |
| 2021 | 11 | 456 | 709 | $77,396 | $24,489 |
| 2020 | 10 | 562 | 803 | $115,536 | $26,741 |
Total Patients
1,867
Total Services
2,843
Medicare Billing
$102,482
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 187 | 403 | $64,480 | $18,066 | 28.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 24 | 24 | $3,744 | $2,531 | 67.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 12 | 12 | $1,080 | $863.16 | 79.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 14 | 14 | $1,330 | $513.24 | 38.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 47 | 57 | $1,539 | $433.77 | 28.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 12 | 12 | $804.00 | $302.76 | 37.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 20 | 25 | $750.00 | $238.00 | 31.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 27 | 39 | $780.00 | $85.80 | 11.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 220 | 405 | $64,800 | $18,879 | 29.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 68 | 93 | $8,835 | $2,683 | 30.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 21 | 21 | $3,348 | $2,235 | 66.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 28 | 29 | $2,610 | $1,981 | 75.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 28 | 29 | $1,943 | $687.97 | 35.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 11 | 11 | $2,420 | $666.91 | 27.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 51 | 55 | $1,205 | $414.99 | 34.4% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 23 | 27 | $700.00 | $259.00 | 37.0% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 12 | 14 | $1,036 | $199.02 | 19.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 11 | 15 | $1,065 | $111.51 | 10.5% |
| 81003 | Automated urinalysis test | Office | 2022 | 33 | 46 | $920.00 | $102.22 | 11.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 156 | 323 | $51,680 | $15,082 | 29.2% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 78 | 101 | $9,595 | $3,090 | 32.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 23 | 23 | $3,588 | $2,497 | 69.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 24 | 25 | $5,500 | $1,553 | 28.2% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 15 | 15 | $1,350 | $978.90 | 72.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 53 | 59 | $1,180 | $458.43 | 38.9% |
About Stephan Moss
Stephan Moss is a Emergency healthcare provider based in Brigham City, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2018. The National Provider Identifier (NPI) number assigned to this provider is 1063906857.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Stephan Moss has received a total of $3,568 in payments from pharmaceutical and medical device companies, with $963.90 received in 2024. These payments were reported across 206 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($3,568).
As a Medicare-enrolled provider, Moss has provided services to 1,867 Medicare beneficiaries, totaling 2,843 services with total Medicare billing of $102,482. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency
- Other Specialties Family
- Location Brigham City, UT
- Active Since 06/15/2018
- Last Updated 11/21/2018
- Taxonomy Code 163WE0003X
- Entity Type Individual
- NPI Number 1063906857
Products in Payments
- VRAYLAR (Drug) $1,346
- XARELTO (Drug) $278.10
- EVENITY (Biological) $198.64
- UBRELVY (Drug) $165.43
- QULIPTA (Drug) $158.49
- NURTEC ODT (Drug) $146.54
- NEXPLANON (Drug) $91.38
- Vascepa (Drug) $89.90
- LINZESS (Drug) $89.66
- AIRSUPRA (Drug) $89.27
- BREZTRI (Drug) $81.03
- ZENPEP (Drug) $65.14
- Otezla (Drug) $61.56
- CREON (Drug) $54.46
- Veozah (Drug) $50.50
- ENTRESTO (Drug) $43.60
- TRELEGY ELLIPTA (Drug) $40.23
- TROKENDI XR (Drug) $33.94
- CAPLYTA (Drug) $29.62
- TRULICITY (Drug) $27.80
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.